Meyerhoff Scholar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The College of Engineering's National Society of Black Engineers and the Office of Community and Engagement are excited to host a discussion titled

“The Chancellor’s Science Scholars program does not exist to give underrepresented minorities a chance — that is not the correct way to look at it,” said Richard Watkins ’14 (Ph.D.), program coordinator for the Chancellor’s Science Scholars. “What we are doing is creating the best scientists the world has ever seen, and there is not a certain look to that. There is no rhyme or reason to who ends up being the best — you don’t know who will have that breakthrough that’s going to save the world.” Take UNC-Chapel Hill graduate Dr. Kizzmekia Corbett ’14 (Ph.D.), the Nationa...

UNC alumna Dr. Kizzmekia Corbett is one of the lead scientists for Moderna's coronavirus vaccine. The Board of Commissioners honored the Orange County native by declaring Jan. 20 "Dr. Kizzmekia S. Corbett Day."

(Photo : Twitter@@amydiehl) African-American Scientist Leads Vaccine Research The federal government has invested billions of dollars in the development of the COVID-19 vaccine that will end the global pandemic. When Pres. Trump visited the National Institutes of Health last March, the leads of the vaccine research explained their mission. The key to the success of the agency's mission is the 34-year-old African-American female scientist Dr. Kizzmekia Corbett. During the "CBS This Morning: Saturday," she told the co-host Michelle Miller that she was just there telling the COVID-19 Task Force...

Meet the Black female scientist at the forefront of COVID-19 vaccine development When President Donald Trump paid a visit to the National Institutes of Health last March, the leads at the vaccine research center explained their life-saving mission. The key to that mission was a 34-year-old doctor named Dr. Kizzmekia Corbett. "I was just there telling the task force about the work that we've been doing," Corbett told "CBS This Morning: Saturday" co-host Michelle Miller. Two weeks after the visit, Corbett's team began the first stage of clinical trials. She said they took a lot of the knowled...